Title: MiRNA Sequencing and Assay Market to Grow at a CAGR of 11.9% to reach US$ 468.99 Million from 2020 to 2027
1MiRNA Sequencing and Assay Market
MiRNA Sequencing and Assay Market Forecast to
2027 - COVID-19 Impact and Global Analysis By
Product (Library Preparation and Consumables),
Technology (Sequencing By Synthesis, Nanopore,
and Ion Semiconductor Sequencing), and End User
(Research Institute, Academia, and CRO) By
Geography
2Current and future Market Scenario
MiRNA Sequencing and Assay Market
- According to our new market research study on
MiRNA Sequencing and Assay Market to 2028
Global Analysis and Forecast by Type,
Treatment, and End User, the market is expected
to reach US 468.99 million by 2027 from US
192.31 million in 2019 it is estimated to grow
at a CAGR of 11.9 from 2020 to 2027. - The growth of the miRNA sequencing and assay
market is mainly attributed to the widening range
of miRNA applications and rise in funding for
genomics research. However, the challenges
related to delivery, efficacy, and specificity of
miRNA-based therapeutics may hinder the market
growth.
3Market Segments
MiRNA Sequencing and Assay Market
By Technology Sequencing by Synthesis Nanopore Io
n Semiconductor Sequencing
By Product Library Preparation Consumables
By End User Research Institute Academia CRO
4Leading Players
MiRNA Sequencing and Assay Market
Company Profiles in MiRNA Sequencing and Assay
Market are Illumina Inc. Thermo Fisher
Scientific Inc. Qiagen Perkin Elmer Inc. Takara
Bio Inc. New England Biolabs NorgenBiotek
Corp TriLinkBioTechnologies Inc Lexogen
GmbH Oxford Nanopore Technologies
5 MiRNA Sequencing and Assay Market
Access Full Research Report at
https//www.theinsightpartners.com/reports/MiRNA
Sequencing and Assay-market
Thank You!